Explore our
Portfolio of Niche Generic and Differentiated Finished Formulations for Human and Animal Health
Meloxicam Chewable Tablets
Therapeutic category | Pain (NSAID) |
Product Name | Meloxicam Chewable tablets |
Dosage form | Tablet |
Strength | 1mg & 2.5mg |
IP and Exclusivity | Expired |
Emerging Market | Dossier Available from GMP approved facility |
Regulated market – Stage and Next steps | Lab Scale Development completed (EU); Technology Transfer and Bioequivalence study |
Commercialization Support for regulated market | Supply form EU GMP approved facility |
Unique Selling Points (USPs) | Palatable chewable bioequivalent formulation |